Cognition Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Cognition Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CGTX | Cognition Therapeutics | -$0.25 | -$0.09 | — | — | $0.00 | — | — | — | 11/12/2025 | |
CGTX | Cognition Therapeutics | -$0.18 | -$0.11 | -$0.11 | 0.00% | $0.00 | — | $0.00 | — | 08/07/2025 | |
CGTX | Cognition Therapeutics | -$0.27 | -$0.11 | -$0.14 | -16.67% | $0.00 | — | $0.00 | — | 05/07/2025 | |
CGTX | Cognition Therapeutics | -$0.27 | -$0.14 | -$0.17 | -13.33% | $0.00 | — | $0.00 | — | 03/20/2025 | |
CGTX | Cognition Therapeutics | -$0.22 | -$0.21 | -$0.25 | -13.64% | $0.00 | — | $0.00 | — | 11/13/2024 | |
CGTX | Cognition Therapeutics | -$0.16 | -$0.24 | -$0.18 | 21.74% | $0.00 | — | $0.00 | — | 08/08/2024 | |
CGTX | Cognition Therapeutics | -$0.21 | -$0.29 | -$0.27 | 6.90% | $0.00 | — | $0.00 | — | 05/07/2024 | |
CGTX | Cognition Therapeutics | -$0.20 | -$0.34 | -$0.27 | — | $0.00 | — | $0.00 | — | 03/26/2024 | |
CGTX | Cognition Therapeutics | -$0.29 | -$0.24 | -$0.22 | 8.33% | $0.00 | — | $0.00 | — | 11/02/2023 | |
CGTX | Cognition Therapeutics | -$0.25 | -$0.19 | -$0.16 | 15.79% | $0.00 | — | $0.00 | — | 08/08/2023 | |
CGTX | Cognition Therapeutics | -$0.17 | -$0.17 | -$0.21 | -23.53% | $0.00 | — | $0.00 | — | 05/04/2023 | |
CGTX | Cognition Therapeutics | -$11.74 | -$0.22 | -$0.20 | 9.09% | $0.00 | — | $0.00 | — | 03/23/2023 | |
CGTX | Cognition Therapeutics | -$8.12 | -$0.38 | -$0.29 | 23.68% | $0.00 | — | $0.00 | — | 11/14/2022 | |
CGTX | Cognition Therapeutics | -$4.77 | -$0.32 | -$0.25 | 21.88% | $0.00 | — | $0.00 | — | 08/09/2022 | |
CGTX | Cognition Therapeutics | -$1.64 | — | -$0.17 | — | $0.00 | — | $0.00 | — | 05/11/2022 | |
CGTX | Cognition Therapeutics | -$5.42 | -$0.26 | -$11.74 | -4415.38% | $0.00 | — | $0.00 | — | 03/30/2022 | |
CGTX | Cognition Therapeutics | -$5.31 | — | -$8.12 | — | $0.00 | — | $0.00 | — | 11/18/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-07 | $-0.11 | $-0.11 | 0.00 % |
Q1 | 2025-05-07 | $-0.14 | $-0.11 | -16.7 % |
Q4 | 2025-03-20 | $-0.17 | $-0.14 | -13.3 % |
Q3 | 2024-11-13 | $-0.25 | $-0.21 | -13.6 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Si prevede che Cognition Therapeutics (CGTX) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il agosto 7, 2025 per il Q2.
L'EPS effettivo era $-0.11, che mancato la stima di $-0.11.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.